欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1173/002
药品名称
Enalapril + Lercanidipina Teva
活性成分
Enalapril maleate 20.0 mg
Lercanidipine hydrochloride 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva Pharma - Produtos Farmacêuticos, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Enalapril/Lercanidipin-ratiopharm 20 mg/10 mg Filmtabletten
France (FR)
Italy (IT)
Spain (ES)
许可日期
2014/11/12
最近更新日期
2025/01/10
药物ATC编码
C09BB02 enalapril and lercanidipine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
Enalapril_lercanidipine 10 mg_10 mg fct_PIL_PT_H_1173_18_09_14
Date of last change:2024/09/06
Final Product Information
|
Enalapril_lercanidipine 10 mg_10 mg fct_SmPC_PT_H_1173_18_09_14
Date of last change:2024/09/06
Final Product Information
|
Enalapril_lercanidipine 20 mg_10 mg fct_PIL_PT_H_1173_18_09_14
Date of last change:2024/09/06
Final Product Information
|
Enalapril_lercanidipine 20 mg_10 mg fct_SmPC_PT_H_1173_18_09_14
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase